Literature DB >> 15850805

Amantadine inhibits hepatitis A virus internal ribosomal entry site-mediated translation in human hepatoma cells.

Tatsuo Kanda1, Osamu Yokosuka, Fumio Imazeki, Keiichi Fujiwara, Keiichi Nagao, Hiromitsu Saisho.   

Abstract

The effect of six drugs (amantadine, glycyrrhizin, ribavirin, ursodeoxycholic acid, alcohol, and IFN) on HAV RNA translation from the HAV internal ribosomal entry site (IRES) was investigated using a bicistronic reporter construct containing HAV IRES as intragenic spacer. Huh-7 cells and derivatives were transfected with in vitro transcripts, and the reporter gene activity was determined. IFN suppressed both cap-dependent and HAV IRES-dependent translation, while amantadine specifically inhibited HAV IRES-dependent translation. In contrast to IFN, by reporter assay, amantadine did not activate the interferon-stimulated response element (ISRE) or interferon gamma-activated sequence (GAS)-associated pathways. Immunoblot analysis revealed that amantadine had no effect on PKR and on IFN-regulatory factor-1 (IRF-1) expression. These findings demonstrated a novel antiviral effect of amantadine against HAV with or without HCV infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15850805     DOI: 10.1016/j.bbrc.2005.03.212

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Amantadine and Rimantadine Inhibit Hepatitis A Virus Replication through the Induction of Autophagy.

Authors:  Reina Sasaki-Tanaka; Toshikatsu Shibata; Mitsuhiko Moriyama; Hiroaki Okamoto; Hirofumi Kogure; Tatsuo Kanda
Journal:  J Virol       Date:  2022-08-30       Impact factor: 6.549

2.  Hepatitis A Virus Infection and Molecular Research.

Authors:  Tatsuo Kanda; Reina Sasaki-Tanaka; Shingo Nakamoto
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

3.  Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha.

Authors:  Lingli Yang; Tomoko Kiyohara; Tatsuo Kanda; Fumio Imazeki; Keiichi Fujiwara; Verena Gauss-Müller; Koji Ishii; Takaji Wakita; Osamu Yokosuka
Journal:  Virol J       Date:  2010-09-03       Impact factor: 4.099

4.  Analysis of 5' nontranslated region of hepatitis A viral RNA genotype I from South Korea: comparison with disease severities.

Authors:  Tatsuo Kanda; Sook-Hyang Jeong; Fumio Imazeki; Keiichi Fujiwara; Osamu Yokosuka
Journal:  PLoS One       Date:  2010-12-28       Impact factor: 3.240

5.  Ultra-deep sequencing analysis of the hepatitis A virus 5'-untranslated region among cases of the same outbreak from a single source.

Authors:  Shuang Wu; Shingo Nakamoto; Tatsuo Kanda; Xia Jiang; Masato Nakamura; Tatsuo Miyamura; Hiroshi Shirasawa; Nobuyuki Sugiura; Azusa Takahashi-Nakaguchi; Tohru Gonoi; Osamu Yokosuka
Journal:  Int J Med Sci       Date:  2013-12-20       Impact factor: 3.738

Review 6.  Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus.

Authors:  Tatsuo Kanda; Shingo Nakamoto; Shuang Wu; Masato Nakamura; Xia Jiang; Yuki Haga; Reina Sasaki; Osamu Yokosuka
Journal:  J Clin Transl Hepatol       Date:  2015-09-15

Review 7.  Cell Culture Systems and Drug Targets for Hepatitis A Virus Infection.

Authors:  Tatsuo Kanda; Reina Sasaki; Ryota Masuzaki; Naoki Matsumoto; Masahiro Ogawa; Mitsuhiko Moriyama
Journal:  Viruses       Date:  2020-05-12       Impact factor: 5.048

Review 8.  Current Practice in Bicistronic IRES Reporter Use: A Systematic Review.

Authors:  Guus Gijsbertus Hubert van den Akker; Federico Zacchini; Bas Adrianus Catharina Housmans; Laura van der Vloet; Marjolein Maria Johanna Caron; Lorenzo Montanaro; Tim Johannes Maria Welting
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

9.  Suppression of La antigen exerts potential antiviral effects against hepatitis A virus.

Authors:  Xia Jiang; Tatsuo Kanda; Shuang Wu; Shingo Nakamoto; Kengo Saito; Hiroshi Shirasawa; Tomoko Kiyohara; Koji Ishii; Takaji Wakita; Hiroaki Okamoto; Osamu Yokosuka
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

Review 10.  Molecular biology and inhibitors of hepatitis A virus.

Authors:  Yannick Debing; Johan Neyts; Hendrik Jan Thibaut
Journal:  Med Res Rev       Date:  2013-05-30       Impact factor: 12.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.